TY  - JOUR
AU  - Zeljković, Aleksandra
AU  - Mihajlović, Marija
AU  - Stefanović, Aleksandra
AU  - Zeljković, D.
AU  - Trifunović, B.
AU  - Miljković, Milica
AU  - Spasojević-Kalimanovska, Vesna
AU  - Vekić, Jelena
PY  - 2020
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3739
AB  - Aim: Despite many efforts, reliable biomarkers for the prediction and diagnosis of colorectal cancer (CRC) are still missing. Insulin-like growth factor 1 (IGF-1) and E-cadherin are recognized as potential biomarkers, but their diagnostic capacity is largely unexplored in CRC. The aim of this work is to investigate IGF-1 and E-cadherin levels with respect to various characteristics of CRC and to estimate their diagnostic potential. Method: Seventy CRC patients and 75 healthy individuals were enrolled. IGF-1 and E-cadherin were determined using enzyme-linked immunosorbent assay. The predictive and diagnostic capacities of IGF-1 and E-cadherin were estimated by logistic regression analysis and by determination of the area under the receiver operating characteristic (ROC) curve (AUC). Results: Concentrations of IGF-1 were lower (P = 0.019) while levels of E-cadherin were higher (P < 0.001) in CRC patients than in controls. IGF-1 concentration decreased in parallel with age and progression of CRC (P = 0.023). Also, IGF-1 was higher in men with CRC than in women (P = 0.003). E-cadherin levels were unaffected by variations in either anthropometric characteristics of CRC patients, or localization, grade and stage of the tumour. Both IGF-1 and E-cadherin were independently associated with CRC (P = 0.040; P < 0.001, respectively). The diagnostic accuracy of IGF-1 was estimated as acceptable (AUC = 0.757; P < 0.001), while the diagnostic accuracy of E-cadherin was outstanding (AUC = 0.954; P < 0.001). Conclusions: Decreased IGF-1 and increased E-cadherin levels were found in CRC patients. IGF-1, but not E-cadherin, concentrations differed according to age, gender and stage of CRC. Both markers were independently associated with the presence of the disease, while E-cadherin demonstrated high diagnostic accuracy.
PB  - Blackwell Publishing Ltd
T2  - Colorectal Disease
T1  - Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer
DO  - 10.1111/codi.15360
ER  - 

@article{
author = "Zeljković, Aleksandra and Mihajlović, Marija and Stefanović, Aleksandra and Zeljković, D. and Trifunović, B. and Miljković, Milica and Spasojević-Kalimanovska, Vesna and Vekić, Jelena",
year = "2020",
abstract = "Aim: Despite many efforts, reliable biomarkers for the prediction and diagnosis of colorectal cancer (CRC) are still missing. Insulin-like growth factor 1 (IGF-1) and E-cadherin are recognized as potential biomarkers, but their diagnostic capacity is largely unexplored in CRC. The aim of this work is to investigate IGF-1 and E-cadherin levels with respect to various characteristics of CRC and to estimate their diagnostic potential. Method: Seventy CRC patients and 75 healthy individuals were enrolled. IGF-1 and E-cadherin were determined using enzyme-linked immunosorbent assay. The predictive and diagnostic capacities of IGF-1 and E-cadherin were estimated by logistic regression analysis and by determination of the area under the receiver operating characteristic (ROC) curve (AUC). Results: Concentrations of IGF-1 were lower (P = 0.019) while levels of E-cadherin were higher (P < 0.001) in CRC patients than in controls. IGF-1 concentration decreased in parallel with age and progression of CRC (P = 0.023). Also, IGF-1 was higher in men with CRC than in women (P = 0.003). E-cadherin levels were unaffected by variations in either anthropometric characteristics of CRC patients, or localization, grade and stage of the tumour. Both IGF-1 and E-cadherin were independently associated with CRC (P = 0.040; P < 0.001, respectively). The diagnostic accuracy of IGF-1 was estimated as acceptable (AUC = 0.757; P < 0.001), while the diagnostic accuracy of E-cadherin was outstanding (AUC = 0.954; P < 0.001). Conclusions: Decreased IGF-1 and increased E-cadherin levels were found in CRC patients. IGF-1, but not E-cadherin, concentrations differed according to age, gender and stage of CRC. Both markers were independently associated with the presence of the disease, while E-cadherin demonstrated high diagnostic accuracy.",
publisher = "Blackwell Publishing Ltd",
journal = "Colorectal Disease",
title = "Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer",
doi = "10.1111/codi.15360"
}

Zeljković, A., Mihajlović, M., Stefanović, A., Zeljković, D., Trifunović, B., Miljković, M., Spasojević-Kalimanovska, V.,& Vekić, J.. (2020). Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer. in Colorectal Disease
Blackwell Publishing Ltd..
https://doi.org/10.1111/codi.15360

Zeljković A, Mihajlović M, Stefanović A, Zeljković D, Trifunović B, Miljković M, Spasojević-Kalimanovska V, Vekić J. Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer. in Colorectal Disease. 2020;.
doi:10.1111/codi.15360 .

Zeljković, Aleksandra, Mihajlović, Marija, Stefanović, Aleksandra, Zeljković, D., Trifunović, B., Miljković, Milica, Spasojević-Kalimanovska, Vesna, Vekić, Jelena, "Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer" in Colorectal Disease (2020),
https://doi.org/10.1111/codi.15360 . .